Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study.
Yiran XieHaoxiang ZhuYifei GuoZhenxuan MaXun QiFeifei YangRi-Cheng MaoJi-Ming ZhangPublished in: Canadian journal of gastroenterology & hepatology (2022)
plus NTs may lead to more HBsAg reduction, especially in HBeAg-positive and "add-on" patients.